: News

2,000 Participants Walk For Breast Cancer In Md. And D.C.

Play associated audio

By Jessica Jordan

More than 2,000 men and women are trekking through Maryland and D.C. to raise money for breast cancer research.

These walkers started out in Germantown, Maryland, and after three days of walking, they’ll end up at the National Mall in D.C. Sunday evening. As part of the The Susan G. Komen Three Day Walk For The Cure, each participant will cover a total of 60 miles on foot.

The long walk requires the help of more than 350 volunteers including medical staff who treat foot blisters and muscle pain, problems that aren't proving to be setbacks for most of these walkers,like Marlie Sherer.

“When you see a survivor up there with no hair, who just finished chemo, it makes you put your blisters into perspective. It’s not so hard to walk when people are battling a terrible disease," Sherer says.

Susan G. Komen will sponsor 15 of these three-day walks in cities across the country.

NPR

Villainous Scheme Makes Dozens A Few Minutes Late

A 40-foot inflatable "minion" — the yellow, unintelligible sidekicks from the Despicable Me movies who recently were given their own spinoff — broke loose and blocked traffic in Dublin this week.
WAMU 88.5

The Surprising Roots of Barbecue

We speak with culinary historian Michael Twitty about the roots of familiar southern dishes in African and Native American food traditions.

WAMU 88.5

President Obama's Iran Speech

Veteran journalist Marvin Kalb joins us to discuss the parallels between JFK's nuclear disarmament speech fifty years ago and President Obama's speech on the nuclear deal with Iran.

WAMU 88.5

The Future Of D.C. Taxis: Ernest Chrappah Discusses Competition And Change

The new chairman of the D.C. Taxicab Commission wants to make it a nimble, innovating agency. He discussed those goals and the related challenges with WAMU 88.5's Martin Di Caro.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.